Comparative study between the interaction of dephosphorylated amifostine (WR-1065) and amoxicilline with pBR322 in absence and presence of cisplatin by AFM

被引:5
作者
Amat, E
Prieto, MJ
Moreno, V
机构
[1] Univ Barcelona, Fac Quim, Dept Quim Inorgan, E-08028 Barcelona, Spain
[2] Univ Barcelona, Fac Farm, Dept Fisicoquim, E-08028 Barcelona, Spain
[3] Univ Barcelona, Fac Biol, Dept Microbiol, E-08028 Barcelona, Spain
关键词
amifostine; amoxicilline; cisplatin toxicity; cisplatin chemoprotection; cisplatin AFM study;
D O I
10.1016/j.ijpharm.2003.10.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of the amoxicilline as a possible cisplatin-action protector on pBR322 DNA has been visually studied by atomic force microscopy in comparison with the modifications caused by the controversed cisplatin protector amifostine. Incubation of amoxicilline with the plasmid DNA showed aggregation and compaction of DNA. Cisplatin incubated in the same conditions with DNA produced kinks and super-coiling of the circular form. In the case of previous treatment of DNA with amoxicilline, the characteristic effect of cisplatin is only partially observed. The amoxicilline seemed to control the action of cisplatin on DNA. The initial effect of dephosphorylated amifostine (WR-1065) when this protector was incubated with the plasmid was also the formation of aggregates and the compaction of DNA. However, addition of cisplatin successively after 1 and 2 h showed the characteristic modification caused by cisplatin but only in a decreasing percentage of molecules of DNA. Both molecules, amoxicilline and WR-1065 seem to control the strong direct action of cisplatin on DNA. This effect can justify the role as protecting agent of amifostine on side effects caused by cisplatin and can open new possibilities to other agents like amoxicilline. (C) 2003 Elsevier B.V All rights reserved.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 39 条
[1]   Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat [J].
Bergström, P ;
Johnsson, A ;
Bergenheim, T ;
Henriksson, R .
JOURNAL OF NEURO-ONCOLOGY, 1999, 42 (01) :13-21
[2]   Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography [J].
Bonner, HS ;
Shaw, LM .
JOURNAL OF CHROMATOGRAPHY B, 2000, 739 (02) :357-362
[3]   Quantum molecular simulation of the radioprotection by the aminothiol WR-1065, active metabolite of amifostine (WR-2721).: Part 2.: Modeling of the hydrogen abstraction by C4′ of DNA deoxyribose radical [J].
Broch, H ;
Hamza, A ;
Vasilescu, D .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2001, 538 :117-132
[4]  
CALABROJONES PM, 1988, CANCER RES, V48, P3634
[5]  
Castiglione F, 1999, TUMORI, V85, P85
[6]  
Cervantes G, 1997, Met Based Drugs, V4, P9, DOI 10.1155/MBD.1997.9
[7]   DNA interaction and antitumor activity of a Pt(III) derivative of 2-mercaptopyridine [J].
Cervantes, G ;
Marchal, S ;
Prieto, MJ ;
Pérez, JM ;
González, VM ;
Alonso, C ;
Moreno, V .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 77 (3-4) :197-203
[8]   Pd(II) and Pt(II) D-penicillamine complexes. Crystal structure of a tridentate D-penicillamine cluster of Pd(II) [J].
Cervantes, G ;
Moreno, V ;
Molins, E ;
Quiros, M .
POLYHEDRON, 1998, 17 (19) :3343-3350
[9]   CLINICAL-TRIALS OF WR-2721 AND CIS-PLATINUM [J].
GLOVER, D ;
GRABELSKY, S ;
FOX, K ;
WEILER, C ;
CANNON, L ;
GLICK, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (05) :1201-1204
[10]   PHASE I/II TRIALS OF WR-2721 AND CISPLATINUM [J].
GLOVER, D ;
GLICK, JH ;
WEILER, C ;
FOX, K ;
TURRISI, A ;
KLIGERMAN, MM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1509-1512